Abstract
Flaxseed is a plant that grows and is cultivated in more than 50 countries; the main flax producer countries are Canada, China, the United States, and India. The purpose of the present study was to overview the source, chemical compounds, and mechanisms of the therapeutic effects of this valuable plant. For writing this manuscript, we made a list of relevant keywords and phrases, and then we started searching for studies in PubMed, Scopus, and Web of Science databases. The main constituents of flaxseed include lipids, proteins, lignans, fibers, and minerals. Flaxseed is full of antioxidants such as tocopherols, betacarotene, cysteine, and methionine which result in a decrease in blood pressure, heart disease, hepatic and neurological disorders, and increased insulin sensitivity. Flaxseed is commonly used for its antidiabetic and anticancer activities and also it is beneficial for cardiovascular, gastrointestinal, hepatic, urological, and reproductive disorders, and because of these beneficial effects, it is recognized as a medical plant.
Key Words: Anticancer, Antidiabetic, Anti-oxidant, Biomedical, Flaxseed, Medicinal properties
Introduction
Flaxseed (Linum usitatissimum) has been planted since the initiation of civilization. Linum usitatissimum is the Latin name of flaxseed, which means very beneficial. At first, it emerged in the United States and was used for clothing fiber production (1, 2). Flaxseed is important in the food chain throughout the world because of its physiological advantages in preventing or treatment of diseases as a functional food. Flaxseed has been regarded as a Generally Recognized As Safe (GRAS) source of vitamins, minerals, proteins, and peptides (including bioactive cyclic peptides), lipids (including omega-3 and omega-6 polyunsaturated fatty acids), carbohydrates, lignans, and dietary fiber. Due to its beneficial features for health, it has been applied in specific diets. Due to a 12% growth in the annual rate of the flaxseed global marketing, it can be predicted that its worth may be increased to US$ 1.95 million (3). Many causes lead to the increasing popularity of flaxseed, such as alleviation of cardiovascular diseases, decreasing the risk of cancer, especially breast and prostate cancer, anti-inflammatory effects, lenient impressions, and reduction of menopause signs and osteoporosis (1).
For writing this manuscript, we made a list of relevant keywords and phrases, and then we started searching studies in PubMed, Scopus, and Web of Science dases. This review is an attempt to demonstrate the different biological activities and medical properties of flaxseed as a traditional plant and its components in animal studies and some human trials. Particularly, we focused on the mechanisms underlying flaxseed effects on hepatic, neurological, cardiovascular, gastrointestinal, reproductive, and urological disorders, and also its anti-oxidant, antidiabetic, and anticancer properties.
The keywords that we used were: Flaxseed, anti-oxidant, antidiabetic, anticancer, biomedical, and medicinal properties. The study was conducted between March and June 2020. All the literature found in databases was included but there was a preference towards recent studies.
Source and chemical compounds
Nowadays, flaxseed is planted in more than 50 countries; the main flax producer countries are Canada, China, the United States, and India (4). Flaxseed is found in two types (1) brown and (2) yellow or golden. Brown and yellow flaxseeds have equal numbers of short-chain ω-3 fatty acids and identical nutritional features. A type of flaxseed called solin has a different oil profile and ω-3 fatty acids numbers compared with others. Brown flax is well-known for its usage in paints, varnish, fiber, and livestock feed. Flaxseed has multiple compounds with bioactive plant materials such as oil, protein, lignans, dietary fibers, vitamins (A, C, F, and E), and minerals (P, Mg, K, Na, Fe, Cu, Mn, and Zn) that impact several disorders that are summarized in Table 1 (5).
Table 1.
Biological activities of flaxseed against different disorders based on experimental studies
Authors (year) | Disorder | Target | Effective dose | Main results |
---|---|---|---|---|
Kailash Prasad (2000) (72) | diabetes | rats | 22 mg/kg body weight SDG, orally |
|
Noureddin Soltanian (2018) (73) |
diabetes | human | 10 g of flaxseed pre-mixed in cookies |
|
Pei Hua (2015) (74) |
diabetes | mice | (3, 10, or 30 mg/kg) |
|
Barre et al. (2012) (75) |
diabetes | human | 600 mg total SDG/day |
|
Muslum Gok (2015) (76) |
diabetes | rats | 0.714 g/kg body weight/day; orally flaxseed |
|
Hadjighassem et al. (2015) (77) | healthy people | human | 500 mg of alpha linolenic acid |
|
Saad et al. (2014) (78) | non-alcoholic fatty liver disease | rabbit | 8 mg/kg of ground flaxseed |
|
Xu et al. (2013) (44) | non-alcoholic fatty liver disease | rats | 8 g/kg |
|
Rodriguez et al. (2013) (79) | peripheral artery disease | human | 30 g/d for 6 months |
|
Edel et al. (2015) (80) | CVD | human | 30 g for 12 months |
|
Bloedon et al. (2008) (81) | hypercholesterolemic adults | human | 40 g/day for 10 weeks |
|
Ghule et al. (2015) (34) | cardiac hypertrophy rat model | rats | 400 mg/kg per day for 4 weeks |
|
Hernández-Salazar et al. (2013) (82) | colon cancer | rats | 16 g/d flaxseed for 10 weeks |
|
Palla et al. (2015) (39) | diarrhea | mice | 100, 300, and 500 mg/kg |
|
Millman et al. (2019) (83) | healthy mice | mice | 35% for 10 weeks |
|
Rizwan et al. (2014) (84) | renal toxicity | rats | 15% flaxseed oil by weight to normal diet |
|
Moghimian (2019) (63) | IR injury | rats | 0.4 g/kg |
|
Sankaran et al. (2007) (85) | CKD | rats | 7% flax oil in diet |
|
Jelodar et al. (2018) (86) | PCOS | rats | 200 mg/kg hydroalcoholic extract of flaxseed |
|
Lucas et al. (2002) (33) | menopausal disorder | human | 40 g/day of flaxseed |
|
SDG: secoisolariciresinol diglucoside; MDA: malondialdehyde; WBC-CL: white blood cell; G6PD: glucose-6-phosphate dehydrogenase; 6PGD: 6-phosphogluconate dehydrogenase; GR: glucocorticoid receptor; GST: glutathione S-transferase; LDL: low-density lipoprotein; CVD: cardiovascular disease; TC: total cholesterol; TG: triglyceride; IBS: irritable bowel syndrome; IR: renal ischemia-reperfusion; CKD: chronic kidney disease; PCOs: polycystic ovary syndrome; VEGF: vascular endothelial growth factor; TNFα: tumor necrosis factor α; NaAs: sodium arsenite; pH: potential hydrogen
Flaxseed oil/lipids
Flaxseed is the richest plant source of the ω-3 fatty acid, i.e., α- linolenic acid (ALA). Flaxseed oil is composed of 73% polyunsaturated fatty acids, 18% monosaturated fatty acids, and 9% saturated fatty acids (6, 7). Flaxseed oil is full of anti-oxidants such as tocopherols and betacarotene, nevertheless, common pure flaxseed oil oxidizes quickly after being exploited. The impacts of ALA on different parts of the body are summarized in Figure 1 (6).
Figure 1.
Impacts of α- linolenic acid (ALA) on different parts of the body
Proteins
Flaxseed is built of 20%–30% protein, including almost 80% globulins (linin and conlinin) and 20% glutelin. The nutritional value and amino acid profile of flaxseed and soya are comparable. Flaxseed proteins consist of arginine, aspartic acid, glutamic acid, and a little lysine (8). The risk of cancer is decreased by flaxseed due to its high anti-oxidant levels such as cysteine and methionine. It also alleviates the risk of cardiovascular disease by peptides with bioactivities (9).
Lignans
Two cinnamic acid connections constitute phenolic compounds called plant lignans. Lignans are found everywhere in approximately all plants (10). Lignans are considered as both anti-oxidants and phytoestrogens. Low estrogen activity is exhibited by phytoestrogens in animals and humans. The quantity of lignans in flax is up to 800 times greater than other plants. Mainly secoisolariciresinol diglucoside (SDG) (294–700 mg/100 g), matairesinol (0.55 mg/100 g), lariciresinol (3.04 mg/100 g) and pinoresinol (3.32mg/100 g) construct flaxseed lignans. Ferulic acid (10.9 mg/g), chlorogenic acid (7.5 mg/g), gallic acid (2.8 mg/g) are the most common phenolic acids in defatted flaxseed. Also, other phenolic acids including p-coumaric acid glucosides, hydroxycinnamic acid glucosides, and 4-hydroxybenzoic acid are found to a lesser extent. Bacteria in the gut transform the SDG of flax to the lignans-enterodiol and enterolactone which cause useful outcomes such as estrogenic or anti-estrogenic and anti-oxidant effects (11). The effects of flax lignans in decreasing the progress of malignant tumors particularly hormone-sensitive ones such as breast, endometrium, and prostate cancers are encouraging. The effects of SDG on different parts of the body are summarized in Figure 2 (11).
Figure 2.
Effects of secoisolariciresinol diglucoside (SDG) on different parts of the body
Dietary fiber
Flaxseeds contain both solvable and unsolvable dietary fiber. The glaze of the outer layers of flaxseed turns it into an unrivaled oilseed (8). High advantages and potential functional features of flaxseed mucilage have made so valued. Flaxseed is constructed of 35–45% fiber: two-thirds unsolvable and one-third solvable fiber which comprises cellulose, hemicellulose, and lignin. It seems the mucilage of the seed cover is mainly made of soluble fiber. Mainly water-soluble polysaccharides constitute mucilaginous substances in flaxseed. Utilization conditions affect the recovery and purity of soluble fiber. The effects of fibers on various parts of the body are summarized in Figure 3 (12).
Figure 3.
Effects of fibers on various parts of the body
Minerals
Flaxseed is considered a rich source of minerals particularly phosphorous (650 mg/100 g), magnesium (350–431 mg/100 g), calcium (236–250 mg/100 g), and a low deal of sodium (27 mg/100g). Flaxseed comprises a great deal of potassium 5600–9200 mg/kg and high consumption of potassium reduces the risk of blood platelet aggregation, free radicals in the blood, and stroke. A small water-soluble and fat-soluble vitamin content can be found in flaxseed.
The quantity of γ- tocopherol (vitamin E) reaches up to 39.5 mg/100 g. γ- tocopherol not only acts as an anti-oxidant but also increases sodium expulsion in urine, which results in a decrease in blood pressure, heart disease, and Alzheimer’s risks (13).
Anti-nutritional factors
Anti-nutrients in flaxseed may create negative effects on human health. The main anti-nutrients are cyanogenic glycosides (CG), including linustatin (213–352 mg/100 g), neolinustatin (91–203 mg/100 g), and linmarin (32 mg/100 g). Phytic acid is another anti-nutrient in flaxseed ranging from 23 to 33 g/kg (14). The absorption of calcium, zinc, magnesium, copper, and iron is restricted by phytic acid. It should be noticed that the risk of poisoning with foodstuffs including CG is alleviated by sufficient processing. For example, more than 85 % of linustatin and neolinustatin were detoxified due to the heating of flaxseed for more than 2 hr at 200 °C (15).
Anti-oxidant capacity of flaxseed
Homeostasis is normally protected from reactive oxygen species via an endogenic anti-oxidant defense procedure but our body is constantly susceptible to oxidative attack which leads to oxidative stress (16). Typical anti-oxidant classification contains synthetic and natural s and also another method categorizes anti-oxidants as primary (chain-breaking) anti-oxidants or secondary (preventive) anti-oxidants. Primary anti-oxidants stabilize the radicals directly through mechanisms like donation of a hydrogen atom or single electron transfer, but secondary anti-oxidants inhibit the oxidant-producing pathways (17). It has been demonstrated that flaxseed contains high amounts of natural anti-oxidants. Anti-oxidant capacity and phenolic ingredients of flaxseed have been examined in both in vitro and in vivo models. In many examinations, it has been shown that the anti-oxidant capability of flaxseeds or their extracts is associated with their phenolic content (18). As a result of its in vitro anti-oxidant capacity, SDG is the most examined phenolic component of flaxseed. SDG exhibited anti-oxidant activity by either direct radical scavenging or by inhibition of lipid peroxidation (19, 20). SDG scavenges concentration-dependent produced •OH radical and also inhibited the lipid peroxidation of liver homogenate in a concentration-dependent manner. The useful flaxseed anti-oxidant components aid to restore the increased activity of hepatic enzymes at almost normal levels (21). Furthermore, in another study, it has been manifested that decreased ROS production and elevated ROS elimination result from high consumption of dietary flaxseed which increases anti-oxidant protection. Probably the anti-oxidative activity of flaxseed depends on water-soluble substances. It can be concluded that proteins are vital for the anti-oxidative activity of flaxseed. Anti-oxidative activity of proteins and their roles in activation or elevation of anti-oxidant features of components has been demonstrated (22).
Anti-diabetic effects
Diabetes is a metabolic disease resulting from a deficiency in insulin secretion and insulin function. Diabetes is determined by hyperglycemia, glycosuria, polyuria, polydipsia, polyphagia, devastated glucose tolerance, insulin resistance, hyperlipidemia, and diabetic coma (23). Diabetes is principally categorized into type 1 and type 2. It has been exhibited that biomarkers of oxidative stress are increased in both major forms of diabetes (24). Notable evidence demonstrates that hyperglycemia leads to the production of reactive oxygen species (ROS) which can result in oxidative stress and cellular damage. In hyperglycemia, glucose autoxidation and non-enzymatic glycation of proteins lead to elevation of mitochondrial ROS which causes oxidative stress. Much data manifest the participation of ROS in the beginning and development of diabetes mellitus. It is accepted that vascular complication, especially in type 2 diabetes, is progressed by the crucial role of oxidative stress (25). Progression of diabetic damages depends on different levels of enzymes like catalase (CAT–enzymatic/non-enzymatic), superoxide dismutase (SOD), and glutathione peroxidase (GSH–Px) which make tissues vulnerable to oxidative stress. Increased hepatic gluconeogenesis is the main cause of hyperglycemia in patients with type 2 diabetes (26).
Diabetes is controlled by flaxseed as a natural source. Anti-oxidant activity and decrease of glucose levels in serum caused by inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression are two anti-diabetic mechanisms of flaxseed. It has been presented that plasma glucose homeostasis is affected by SDG-containing foodstuff as well as flaxseed fibers. The creation of diabetes mellitus is inhibited by SDG derived from flaxseed. The amount of lignans in flaxseed is 1000 times more than other food sources such as sesame seed, pumpkin seeds, cereals (wheat), leguminous plants (lentils, soybeans), fruits (pears, prunes), and certain vegetables (garlic, asparagus, carrots), so it is considered as the main source of lignans with SDG as a basic compound. Flax lignan complex (FLC) derived from flaxseed is composed of 34% to 38% SDG, 15% to 21% cinnamic acid glucoside, and 9.6% to 11.0% hydroxymethyl glutaric acid by weight. Insulin resistance in type 2 diabetes which is related to C-reactive protein condensation and progression of diet-induced obesity was decreased by SDG (27). FLC decreased the metabolic syndrome composite score in males; however, no effects were observed in females (28). It was shown that reduction in serum and pancreatic malondialdehyde (MDA) causes decreased oxidative stress which is related to these effects. It was shown that SDG decreases serum MDA and glycated hemoglobin (A1C) levels which are related to delayed development of diabetes in the Zucker fatty rat type 2 diabetes model (29). It can be concluded that SDG delays type 2 diabetes in animal models and causes inhibition and delaying of development of diabetes by decreased oxidative stress and also suppression of PEPCK gene expression results in prevention and delaying of the progression of diabetes.
Effects of flaxseed on cardiovascular diseases
According to the World Health Organization (WHO), cardiovascular diseases (CVD) are the number 1 cause of death globally: 17.9 million people die each year from CVDs. One-third of these statistics are for countries with below-average incomes. A healthy diet and normal body mass index (BMI) can reduce the risk of CVDs. Hypertension, hyperlipidemia, atherosclerosis, and platelet aggregation (30) can be managed by herbal supplements like flaxseed. The most important bioactive components of flaxseed, which have a positive effect on cardiovascular risk factors and CVDs, include α-linolenic acid (ALA), ω-3 (n-3) polyunsaturated fatty acids (PUFAs), lignan phytoestrogen, SDG, and proteins (31).
Many animal and clinical studies have shown the antihypertensive effects of flaxseed. Some interesting research in this field is given below. The prospective, double-blinded, placebo-controlled, randomized trial reported 30 g/day of milled flaxseed for 6 months could reduce blood pressure in patients (32). Flaxseed proteins and peptides, which are rich in arginine residues, display an antihypertensive effect in rats, and also flaxseed fiber in doses 7.2 to 18.9 significantly decreased blood pressure. The majority of animal and clinical studies suggested that consumption of flaxseed products leads to a decrease in serum lipid profile such as total cholesterol (TC), LDL-cholesterol, triglyceride (TG), lipoprotein a (Lp a), Serum apolipoprotein A-1, and apolipoprotein B (33). However, there are conflicting articles against these results, which can be interpreted by animal species, study model, the dose of flaxseed, duration of consumption, and the target studied patients. Flaxseed in animal studies has been shown to reduce arrhythmias, reduce the size of the infarct, reduce apoptosis and inflammatory factors, and enhance the anti-oxidant capacity in the heart (34, 35). Flaxseed can affect the cardiovascular system by the following mechanisms:
1) Flaxseed has a powerful anti-oxidant activity and also it can decrease caloric intake.
2) flaxseed SDG increases the neovascularization in the heart and thereby improves vascular and cardiac function.
3) Flaxseed has shown anti-atherogenic activity, antiplatelet action, and improvement in cardiac cell survival through reducing inflammatory cytokine production, inhibition of anti-aggregatory prostacyclin, and up-regulating anti-apoptotic proteins, respectively.
Effects of flaxseed on gastrointestinal disorders
Gastrointestinal disorders include such conditions as colon cancer, functional gastrointestinal disorders (FGID) such as functional dyspepsia (FD), diarrhea, and irritable bowel syndrome (IBS) as well as inflammatory bowel disease (IBD). Healthy lifestyle, good bowel habits, and performing cancer screening decrease or inhibit gastrointestinal disorders (36). The effects of consuming 50 g/day flaxseed for 4 weeks on different factors of nutrition in young healthy adults were characterized by Cunnane et al. (1995). It was manifested that consuming flaxseed increased bowel movement by 30% per week (P<0.05). Fibers may also play a role through the constitution of small-chain fatty acids, e.g., acetate and propionate. It can be concluded that augmentation of bile acid expulsion rate and decrease of bile acid reabsorption may be affected by these small-chain fatty acids via increased fecal excretion of cholesterol, and increasing colonic mobility, and inciting colonic transit (37). Reciprocally, researchers examined cases with IBS in an open randomized controlled trial. There were no significant changes in stool frequency or stool consistency between control and flaxseed groups (38).
Another theory proposes that the prevention of calcium channels shows antimotility and antisecretory activity which can cause antidiarrheal effects of flaxseed (39). Anaya et al. stated that antinutritional factors and low protein digestibility reduce the nutritional value of flaxseed (40). Besides this, it was presented that digestive enzyme inhibitors of flaxseed impaired rat growth and reduced intestinal villi. Bowel inflammation and functional gastrointestinal diseases are treated by the increase of intestinal bulk which results from the water-binding capacity of the insoluble fiber in flaxseed (37).
The activities of chemoprotection, anti-inflammation, and antimicrobe along with augmentation of bowel movement and releasing bile acid are the advantages of flaxseed consumption as a nutritional supplement. Regulation of expression of genes involved in cell cycle arrest and mitochondrial apoptosis, as well as K+ channel opening mechanism, are two main mechanisms that are involved in the effects of flaxseed on GID.
The effect of flaxseed on hepatic disorders
Redox enzymes and bioenergetic electron transfer living organisms are involved in free radicals and reactive oxygen species (ROS) production from exogenous or endogenous sources. Oxidative stress mediated by free radicals and ROS results in proteins, lipids, and nucleic acid disruption which cause disorders including cancer, diabetes, atherosclerosis, and hepatic diseases. Anti-oxidant compounds play a preventive role in dealing with these molecules (41). Several animal and human models confirmed the anti-oxidant properties of SDG and its metabolites. Reduced levels of total protein and albumin are observed in rabbit induced hepatotoxicity model as compared with the control group. A remarkable supportive effect for SDG is proposed in the liver and renal complications caused by paracetamol-induced hepatonephrotoxicity in rabbits. Accordingly, flaxseed lignan therapeutically is rendered a potential hepato-nephroprotective representative (42). Furthermore, flaxseed supplied appropriate therapeutic management to control hypertriglyceridemia and fatty liver in rats. Another study indicated SDG lignans histological protective effects on non-alcoholic fatty liver disease (NAFLD) in rabbits. Also, reduced liver disease risk factors in hypercholesterolemia are suggested as flaxseed lignan preventive properties. Besides, blood cholesterol decreased following oral administration of SDG in human hypercholesterolemia (43). Collectively, numerous studies showed that flaxseed oil as a rich source of n-3 fatty acids alleviates oxidative stress and lipid accumulation in the liver, suppresses hepatic glycolytic and lipogenic genes, improves insulin sensitivity and reduces fat absorption based on a large amount of lignan and soluble fiber leading to hypolipidemia (44). It must be mentioned that the reduction in the mRNA expression levels of sterol regulatory element binding protein-1c (SREBP-1c), which regulates the activity of cholesterol and fatty acid synthetase enzymes, can lead to enhanced blood cholesterol-lowering effect and reduce the risk factors of liver disease.
Anticancer effects of flaxseed
Improper signaling in biological pathways associated with cell proliferation, inflammation, and oxidative stress, among others cause cancer and other chronic diseases. It is demonstrated that plant foods contain phytochemicals or bioactive compounds such as lignans that reduce cancer risk or progression. Some foods such as fruits, vegetables, seeds, the bran layer of grains, and legumes contain phenolic compounds known as lignans. Today, as a result of the useful health effects of plant lignans such as antitumor, anti-oxidant, both estrogenic, anti-estrogenic activity, and decrease of the risk of developing chronic diseases, especially cancer, they are becoming a great therapeutically active class of compounds. SDG can be converted to mammalian lignans enterodiol and enterolactone by bacteria in the animal or human colon. Flaxseed is considered a great anticancer food because of its significant level of SDG and ALA (45). It has been demonstrated that strong antiproliferative, anti-oxidant, antiestrogenic, and/or anti-angiogenic activities of SDG prevent some malignant tumors such as breast, lung, and colon cancer. The inhibition of enzymes involved in carcinogenesis is the suggested mechanism for the anticancer effect of SDG (43). It has been demonstrated that consuming SDG reduces the volume, area, and number of tumors. The primary risk factor for colon cancer is characterized by the growth of crypts and crypts foci. In several studies, it has been manifested that aberrant crypts and their foci show the anticancer role of flaxseed SDG and lignan supplementation in the diet (46). Colon tumor cell proliferation may be prevented by lignans through apoptosis-mediated cell death and also through their anti-oxidant feature. The circulating level of ALA, EPA, and DHA which were caused by consumption of dietary flaxseed, could be effective for the management of colon cancer. It has been exhibited that dietary phytoestrogens prohibit and treat breast cancer and also result in both weak estrogenic and anti-estrogenic activities (47). It has been shown that α-Linolenic acid has anti-inflammatory effects, and also antiproliferative activities were shown in premenopausal animal models of breast cancer. Angiogenesis is considered a basic step in cancer development. Vascular endothelial growth factor (VEGF) is one of the main stimulants of angiogenesis (48). Already it has been proven that extracellular VEGF increases by estradiol (E2) in cancerous and normal human breast tissue in vivo. In a study, it has been presented that estrogen receptor-positive breast cancer may be prevented by the anti-estrogenic effects of flaxseed and its lignans (49). Breast cancer is prevented by SDG through modification of the expression level of zinc transporters since the zinc levels in breast cancer cells are more than normal ones (50). In a study on 14 healthy men, it was presented that diets of 50 to 60 g of fiber from mixed sources decrease prostate-specific antigen (PSA) (51). Researchers demonstrated that the risk of prostate cancer is directly associated with prostatic fluid lignin levels (52). Flaxseed contains many dietary lignans. It has been demonstrated that total and free testosterone and 5α-reductase (testosterone converter enzyme to dihydrotestosterone) are decreased by lignans. In a hormone-related neoplasm such as prostate cancer, these effects may be important (53). Flaxseed is a rich source of plant-based N-3 fatty acids (N3FA), which have been shown to play important roles like increasing the natural killer cell activity, changing the tyrosine kinase cell signaling pathways, preventing the cell membrane synthesis, influence cell receptor status, and impact the eicosanoid milieu (suppressed production of prostaglandins E2 and 5-hydroxyeicosatetraenoic acid) via cyclooxygenase and lipoxygenase pathways (53).
It can be concluded that some of the compounds, such as lignans (through antitumor, anti-oxidant, both estrogenic, anti-estrogenic activity), modulate the signaling mechanism of cell proliferation, inflammation, and oxidative stress and thereby can reduce the risk of cancer or its progression.
The effect of flaxseed on urological disorders
The kidney is the main target organ for noxious components (54). Throughout the world, kidney failures are considered an important health problem. Also, the percentage of deaths increases due to renal dysfunctions yearly (55). Different reasons such as chemical toxicity, sepsis, and trauma cause acute renal damage. Globally, medical herbs play an important role in the treatment of several illnesses (56). Exacerbation of renal injury and development of chronic renal failure is directly associated with high protein consumption. Moreover, renal function and renal disease may be improved by changing the source or type of dietary protein (57). Plant seeds, especially flaxseed, play an important role in the treatment of chronic renal disease and human lupus nephritis. It was demonstrated that flaxseed consumption instead of dietary protein decrease proteinuria and glomerular and tubulointerstitial lesions in obese SHR/N-cp rats and also flaxseed meal decreases proteinuria and renal histologic abnormalities more effectively, compared with soybeans (58). Evidence showed that mortality, proteinuria, and decline in glomerular filtration rate (GFR) are reduced by flaxseed diet (59).
In several studies, it was exhibited that thioacetamide-induced renal injury is prevented by flaxseed oil and its anti-oxidant activity causes the protective effect (60). Severe renal injuries among older adults who are dependent on dialysis or transplantation for survival can be created by chronic kidney disease (CKD). Both flaxseed oil either used as a food or as a curative supplement and whole flaxseed may have similar effects on the treatment of renal injury (61).
In a study, nephroprotective effect of ethanolic extract of flaxseed/L. Usitatissimum (EELU) in high dose in gentamycin-induced nephrotoxicity model in Wistar rats and its anti-oxidant potential in the prevention of acute kidney injury was introduced. Acute kidney injury is primarily created due to renal ischemia-reperfusion (IR) (62). Disorders in Cellular Ca2+ metabolism, high levels of free radicals, and generation of toxic lipid metabolites were suggested as involved mechanisms in this respect. IR-induced acute kidney injury can be prevented by supplementations with omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are the principal (n-3) polyunsaturated fatty acids (PUFA) found in fish. The results demonstrate the beneficial effects of flaxseed and fish oil in the reduction of IR-induced renal injury. It was manifested that histological and oxidative stress damages were decreased by 4-week treatment with flaxseed oil and fish oil (63).
The effect of flaxseed on reproductive disorders
The valuable effects of lignan complex and alpha-linolenic acid from flaxseed on reproductive disorders have been investigated (64). It was shown that early malnutrition-associated changes are reversed by flaxseed flour (contained 17% protein, 45% carbohydrate, 26% fat, and fibers) or oil (contained 13% linoleic acid and 52% α-linolenic acid).
Polycystic ovary syndrome (PCOS) is a female hormone-related disorder. Hormonal imbalance in PCOS often causes infertility problems in women. Androgen levels of plasma mostly increase in PCOS patients. Elevated production of androgens in PCOS patients can be caused by activation of the hypothalamic-pituitary-adrenal (HPA) axis due to metabolic disorders such as insulin resistance. Changing of lifestyle, surgery, and medication such as clomiphene citrate, metformin, letrozole, and tamoxifen have been suggested as curative methods for PCOS (65). Today, herbal medicines have become a popular method in the treatment or control of the disease. In a case study, it was manifested that flaxseed consumption (30 g/day for 4 months) decreased testosterone and increased the insulin level in a 31-years old woman with PCOS (66). In many studies, it was reported that flaxseed lignans decrease the excess testosterone which is responsible for PCOS pathogenesis. Any substances that can decrease androgen levels will be beneficial in androgen-dependent disorders such as PCOS. In a study, it was demonstrated that flaxseed consumption not only decreases the ovarian volume and number of follicles in polycystic ovaries but also regulates the rate of menstrual cycles without any effects on body weight, blood sugar, and hirsutism. Improvement of follicular maturation and the anti-inflammatory effect to decrease ovarian volume result from the effect of FSP by the reduction in testosterone, estrogen, LH, and insulin levels. As a result of beneficial effects on ovarian function and menstrual cycle, flaxseed is suggested to be a drug source for PCOS treatment (67).
As a result of reduction in the circulating levels of estrogen, menopausal women are more susceptible to cardiovascular disease (CVD). Disorders of menopause are related to a more atherogenic lipid profile and changed vascular responsiveness. It has been demonstrated that endothelial activity which plays an important role in development, progression, and clinical manifestations of atherosclerosis and aorta distensibility decrease around the time of menopause (68).
Disease prevention should occur during life, beginning with the mother’s diet during gestation, throughout lactation, and into adulthood (69). In several studies, it has been manifested that prenatal and primary postnatal nutrition affect the susceptibility to chronic diseases related to obesity, hypertension, and cardiovascular diseases in adulthood (70). As a result of the beneficial effects of functional foods such as flaxseed in the prevention of diseases as well as their role in losing weight and decreasing body mass index (BMI) they have been studied frequently (71).
Conclusion
Flaxseed has multiple compounds with bioactive plant materials such as oils, lignans, vitamin E, dietary fibers, and potassium and is full of anti-oxidant activity and by this activity, reduces the risk of cancer, diabetes, and renal injury and also prevents malignant tumors in the breast, lungs, and colon. Direct radical scavenging and inhibition of lipid peroxidation are the two major mechanisms of the anti-oxidant activity of flaxseed. The peptides and potassium of flaxseed reduce the risk of blood platelet aggregation, blood pressure, and free radicals in the blood and finally decrease the risk of cardiovascular disease. Due to its role in increasing the excretion of sodium in urine, Vitamin E is an important component of flaxseed which leads to a decrease in blood pressure and heart disease. Prevention of calcium channels shows antimotility and antisecretory activity which can cause antidiarrheal effects of flaxseed. Flaxseed oil decreases the accumulation of lipids, suppresses hepatic glycolytic and lipogenic genes, improves insulin sensitivity, and reduces fat absorption. Based on the information and mechanisms mentioned above, flaxseed is recognized as a medical plant. Future studies may challenge what we now believe about the therapeutic effects of flaxseed or confirm the mentioned findings. We believe that more clinical studies are needed to present a complete list of flaxseed effects.
References
- 1.Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Technol. 2014;51:1633–1653. doi: 10.1007/s13197-013-1247-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bagheri A, Talei S, Hassanzadeh N, Mokhtari T, Akbari M, Malek F, et al. The neuroprotective effects of flaxseed oil supplementation on functional motor recovery in a model of ischemic brain stroke: upregulation of BDNF and GDNF. Acta Med Iran. 2017;55:785–792. [PubMed] [Google Scholar]
- 3.Dzuvor CKO, Taylor JT, Acquah C, Pan S, Agyei D. Bioprocessing of functional ingredients from flaxseed. Molecules. 2018;23:2444. doi: 10.3390/molecules23102444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Rubilar M, Gutiérrez C, Verdugo M, Shene C, Sineiro J. Flaxseed as a source of functional ingredients. J Soil Sci Plant Nutr. 2010;10:373–377. [Google Scholar]
- 5.Ivanov S, Rashevskaya T, Makhonina M. Flaxseed additive application in dairy products production. Procedia Food Sci. 2011;1:275–280. [Google Scholar]
- 6.Pellizzon MA, Billheimer JT, Bloedon LT, Szapary PO, Rader DJ. Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models. J Am Coll Nutr. 2007;26:66–75. doi: 10.1080/07315724.2007.10719587. [DOI] [PubMed] [Google Scholar]
- 7.Cunnane SC, Ganguli S, Menard C, Liede AC, Hamadeh MJ, Chen Z-Y, et al. High α-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr. 1993;69:443–453. doi: 10.1079/bjn19930046. [DOI] [PubMed] [Google Scholar]
- 8.Singh K, Jhamb S, Kumar R. Effect of pretreatments on performance of screw pressing for flaxseed. J Food Process Eng. 2012;35:543–556. [Google Scholar]
- 9.Wu S, Wang X, Qi W, Guo Q. Bioactive protein/peptides of flaxseed: A review. Trends Food Sci Tech. 2019;92:184–193. [Google Scholar]
- 10.Tarpila A, Wennberg T, Tarpila S. Flaxseed as a functional food. Curr Top Nutraceutical Res. 2005;3:167–188. [Google Scholar]
- 11.Di Y, Jones J, Mansell K, Whiting S, Fowler S, Thorpe L, et al. Influence of flaxseed lignan supplementation to older adults on biochemical and functional outcome measures of inflammation. J Am Coll Nutr. 2017;36:646–653. doi: 10.1080/07315724.2017.1342213. [DOI] [PubMed] [Google Scholar]
- 12.Kajla P, Sharma A, Sood DR. Flaxseed—a potential functional food source. J Food Sci Technol. 2015;52:1857–1871. doi: 10.1007/s13197-014-1293-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Raghuwanshi V, Agrawal R, Mane K. Flaxseed as a functional food: a review. J Pharmacogn Phytochem. 2019;8:352–354. [Google Scholar]
- 14.Oomah DB, Mazza G, Kenaschuk EO. Dehulling characteristics of flaxseed. LWT-Food Sci Technol. 1996;29:245–250. [Google Scholar]
- 15.Park E-R, Hong J-H, Lee D-H, Han S-B, Lee K-B, Park J-S, et al. Analysis and decrease of cyanogenic glucosides in flaxseed. J Korean Soc Food Sci Nutr. 2005;34:875–879. [Google Scholar]
- 16.Ebrahimi B, Forouzanfar F, Azizi H, Khoshdel-Sarkarizi H, Sadeghnia H, Rajabzadeh A. Effect of electroacupuncture and glibenclamide on blood glucose level and oxidative stress parameters in streptozotocin-induced diabetic rats and possible human implications. Acupunct Electrother Res. 2020;44:213–228. [Google Scholar]
- 17.Schwarz K, Bertelsen G, Nissen LR, Gardner PT, Heinonen MI, Hopia A, et al. Investigation of plant extracts for the protection of processed foods against lipid oxidation Comparison of anti-oxidant assays based on radical scavenging, lipid oxidation and analysis of the principal anti-oxidant compounds. Eur Food Res Technol. 2001;212:319–328. [Google Scholar]
- 18.Pham LB, Wang B, Zisu B, Adhikari B. Covalent modification of flaxseed protein isolate by phenolic compounds and the structure and functional properties of the adducts. Food Chem. 2019;293:463–471. doi: 10.1016/j.foodchem.2019.04.123. [DOI] [PubMed] [Google Scholar]
- 19.Gholaminejhad M, Arabzadeh S, Akbari M, Mohamadi Y, Hassanzadeh G. Anti-oxidative and neuroprotective effects of flaxseed on experimental unilateral spinal cord injury in rat. J Contemp Med Sci . 2017;3:213–217. [Google Scholar]
- 20.Navaie F, Hassanzadeh G, Mahakizadeh S, Mehrannia K, Alizamir T, Dashti N, et al. Anti-oxidative and neuroprotective effects of supplementary flaxseed on oxidative damage in the hippocampus area of a rat model of hypoxia. Arch Neuro Sci. 2018;5:e60193. [Google Scholar]
- 21.Rajesha J, Murthy KNC, Kumar MK, Madhusudhan B, Ravishankar GA. Anti-oxidant potentials of flaxseed by in vivo model. J Agric Food Chem. 2006;54:3794–3799. doi: 10.1021/jf053048a. [DOI] [PubMed] [Google Scholar]
- 22.Sheih I-C, Wu T-K, Fang TJ. Anti-oxidant properties of a new anti-oxidative peptide from algae protein waste hydrolysate in different oxidation systems. Bioresour Technol. 2009;100:3419–3425. doi: 10.1016/j.biortech.2009.02.014. [DOI] [PubMed] [Google Scholar]
- 23.Ebrahimi B, Azizi H, Sarkarizi HK, Bahrami-Taghanaki H, Rajabzadeh A. Comparing the effect of electroacupuncture and glibenclamide on blood glucose level and histological markers of pancreas in streptozotocin-induced diabetic rats. Altern Ther Health Med. 2020;26:12–19. [PubMed] [Google Scholar]
- 24.Bafadam S, Beheshti F, Khodabakhshi T, Asghari A, Ebrahimi B, Sadeghnia HR, et al. Trigonella foenum-graceum seed (fenugreek) hydroalcoholic extract improved the oxidative stress status in a rat model of diabetes-induced memory impairment. Horm Mol Biol Clin Investig. 2019;39:1–13. doi: 10.1515/hmbci-2018-0074. [DOI] [PubMed] [Google Scholar]
- 25.Pham-Huy LA, He H, Pham-Huy C. Free radicals, anti-oxidants in disease and health. Int J Biomed Sci. 2008;4:89–96. [PMC free article] [PubMed] [Google Scholar]
- 26.Ren T, Ma A, Zhuo R, Zhang H, Peng L, Jin X, et al. Oleoylethanolamide increases glycogen synthesis and inhibits hepatic gluconeogenesis via the LKB1/AMPK pathway in type 2 diabetic model. J Pharmacol Exp Ther. 2020;373:81–91. doi: 10.1124/jpet.119.262675. [DOI] [PubMed] [Google Scholar]
- 27.Prasad K, Dhar A. Flaxseed and diabetes. Curr Pharm Des. 2016;22:141–144. doi: 10.2174/1381612822666151112151230. [DOI] [PubMed] [Google Scholar]
- 28.Prasad K. Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: effect of secoisolariciresinol diglucoside (SDG) Mol Cell Biochem. 2000;209:89–96. doi: 10.1023/a:1007079802459. [DOI] [PubMed] [Google Scholar]
- 29.Kezimana P, Dmitriev AA, Kudryavtseva AV, Romanova EV, Melnikova NV. Secoisolariciresinol diglucoside of flaxseed and its metabolites: Biosynthesis and potential for nutraceuticals. Front Genet. 2018;9:641–650. doi: 10.3389/fgene.2018.00641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hsia DS, Zhang DJ, Beyl RS, Greenway FL, Khoo C. Effect of daily consumption of cranberry beverage on insulin sensitivity and modification of cardiovascular risk factors in obese adults: a pilot randomized placebo-controlled study. Br J Nutr. 2020;124:577–585. doi: 10.1017/S0007114520001336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Saleem MH, Ali S, Hussain S, Kamran M, Chattha MS, Ahmad S, et al. Flax (Linum usitatissimum L ): a potential candidate for phytoremediation? biological and economical points of view. Plants (Basel) 2020;9:496–512. doi: 10.3390/plants9040496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62:1081–1089. doi: 10.1161/HYPERTENSIONAHA.113.02094. [DOI] [PubMed] [Google Scholar]
- 33.Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, Daggy BP, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab. 2002;87:1527–1532. doi: 10.1210/jcem.87.4.8374. [DOI] [PubMed] [Google Scholar]
- 34.Ghule AE, Kandhare AD, Jadhav SS, Zanwar AA, Bodhankar SL. Omega-3-fatty acid adds to the protective effect of flax lignan concentrate in pressure overload-induced myocardial hypertrophy in rats via modulation of oxidative stress and apoptosis. Int Immunopharmacol. 2015;28:751–763. doi: 10.1016/j.intimp.2015.08.005. [DOI] [PubMed] [Google Scholar]
- 35.Parikh M, Netticadan T, Pierce GN. Flaxseed: its bioactive components and their cardiovascular benefits. Am J Physiol Heart Circ Physiol. 2018;314:146–159. doi: 10.1152/ajpheart.00400.2017. [DOI] [PubMed] [Google Scholar]
- 36.David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563. doi: 10.1038/nature12820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Laurino C, Palmieri B, Vadalà M. Gastrointestinal activity of dietary flaxseed lignans, omega-3 fatty acids and fibres. Nutrafoods . 2017:1–9. [Google Scholar]
- 38.Cockerell KM, Watkins AS, Reeves LB, Goddard L, Lomer MC. Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial. J Hum Nutr Diet. 2012;25:435–443. doi: 10.1111/j.1365-277X.2012.01263.x. [DOI] [PubMed] [Google Scholar]
- 39.Palla AH, Khan NA, Bashir S, Iqbal J, Gilani A-H. Pharmacological basis for the medicinal use of Linum usitatissimum (Flaxseed) in infectious and non-infectious diarrhea. J Ethnopharmacol. 2015;160:61–68. doi: 10.1016/j.jep.2014.11.030. [DOI] [PubMed] [Google Scholar]
- 40.Anaya K, Cruz AC, Cunha DC, Monteiro SM, Dos Santos EA. Growth impairment caused by raw linseed consumption: can trypsin inhibitors be harmful for health? plant foods Hum Nutr. 2015;70:338–343. doi: 10.1007/s11130-015-0500-y. [DOI] [PubMed] [Google Scholar]
- 41.Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interaction among dietary anti-oxidants and reactive oxygen species. J Nutr Biochem. 2007;18:567–579. doi: 10.1016/j.jnutbio.2006.10.007. [DOI] [PubMed] [Google Scholar]
- 42.Al-Jumaily E, Al-Azawi A. Hepatoprotective activity of lignan compound from flaxseed (linumusitatissimum l ) against acetaminopheninduced hepatotoxicity in rabbits. World J Pharma Pharmaceut Sci. 2013;3:56–72. [Google Scholar]
- 43.Imran M, Ahmad N, Anjum FM, Khan MK, Mushtaq Z, Nadeem M, et al. Potential protective properties of flax lignan secoisolariciresinol diglucoside. Nutr J. 2015;14:71–77. doi: 10.1186/s12937-015-0059-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Xu J, Gao H, Song L, Yang W, Chen C, Deng Q, et al. Flaxseed oil and alpha-lipoic acid combination ameliorates hepatic oxidative stress and lipid accumulation in comparison to lard. Lipids Health Dis. 2013;12:58–64. doi: 10.1186/1476-511X-12-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.DeLuca JA, Garcia-Villatoro EL, Allred CD. Flaxseed bioactive compounds and colorectal cancer prevention. Curr Oncol Rep. 2018;20:59–66. doi: 10.1007/s11912-018-0704-z. [DOI] [PubMed] [Google Scholar]
- 46.Lin Z, Taibi A, Lepp D, Power K, Thompson L, Comelli E. Effect of continuous administration of flaxseed and flaxseed components on the gut microbiota in female mice. J Can Assoc Gastroenterol. 2018;1:453. [Google Scholar]
- 47.Li L, Chen X, Liu CC, Lee LS, Man C, Cheng SH. Phytoestrogen bakuchiol exhibits in vitro and in vivo anti-breast cancer effects by inducing S phase arrest and apoptosis. Front Pharmacol. 2016:7:128–141. doi: 10.3389/fphar.2016.00128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kumaresan Indrapriyadharshini M, Sekar B, Ambika Murugesan M, Thuckanickenpalayam Ragunathan Yoithapprabhunath M. Role of vascular endothelial growth factor (VEGF) in tumor progression among oral epithelial dysplasia (OEDs), verrucous carcinoma (VC) and oral squamous cell carcinoma (OSCC)–An Immunohistochemical Study. Int J Adv Sci Technol . 2019;28:720–728. [Google Scholar]
- 49.Jungeström MB, Thompson LU, Dabrosin C. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res. 2007;13:1061–1067. doi: 10.1158/1078-0432.CCR-06-1651. [DOI] [PubMed] [Google Scholar]
- 50.Zhang L-y, Wang X-l, Sun D-x, Liu X-x, Hu X-y, Kong F. Regulation of zinc transporters by dietary flaxseed lignan in human breast cancer xenografts. Mol Biol Rep. 2008;35:595–600. doi: 10.1007/s11033-007-9129-8. [DOI] [PubMed] [Google Scholar]
- 51.Tariq N, Jenkins DJ, Vidgen E, Fleshner N, Kendall CW, Story JA, et al. Effect of soluble and insoluble fiber diets on serum prostate specific antigen in men. J Urol. 2000;163:114–118. [PubMed] [Google Scholar]
- 52.Morton M, Chan P, Cheng C, Blacklock N, Matos-Ferreira A, Abranches-Monteiro L, et al. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 1997;32:122–128. doi: 10.1002/(sici)1097-0045(19970701)32:2<122::aid-pros7>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- 53.Nelson W, De Matzo A. lsaacs WB. Prostate cancer N Engl I Med. 2003;349:366–381. doi: 10.1056/NEJMra021562. [DOI] [PubMed] [Google Scholar]
- 54.Kim SY, Moon A. Drug-induced nephrotoxicity and its biomarkers. Biomol Ther. 2012;20:268–272. doi: 10.4062/biomolther.2012.20.3.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int. 2005;68:7–10. doi: 10.1111/j.1523-1755.2005.09801.x. [DOI] [PubMed] [Google Scholar]
- 56.Mamun M, Billah M, Ashek M, Ahasan M, Hossain M, Sultana T. Evaluation of diuretic activity of Ipomoea aquatica (Kalmisak) in mice model study. J Med Sci. 2003;3:395–400. [Google Scholar]
- 57.Mokhtari T, Faghir Ghanesefat H, Hassanzadeh G, Moayeri A, Haeri SMJ, Rezaee Kanavee A, et al. Effects of Flaxseed oil supplementation on renal dysfunction due to ischemia/reperfusion in rat. J Basic Res Med Sci. 2017;4:22–29. [Google Scholar]
- 58.Velasquez MT, Bhathena S, Ranich T, Schwartz AM, Kardon DE, Ali A, et al. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney Int. 2003;64:2100–2107. doi: 10.1046/j.1523-1755.2003.00329.x. [DOI] [PubMed] [Google Scholar]
- 59.Clark WF, Parbtani A, Huff MW, Spanner E, de Salis H, Chin-Yee I, et al. Flaxseed: a potential treatment for lupus nephritis. Kidney Int. 1995;48:475–480. doi: 10.1038/ki.1995.316. [DOI] [PubMed] [Google Scholar]
- 60.Omar AMS. The potential protective influence of flaxseed oil against renal toxicity induced by thioacetamide in rats. Saudi J Biol Sci. 2018;25:1696–1702. doi: 10.1016/j.sjbs.2016.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Aukema H. Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n− 6/n− 3 FA ratio in experimental polycystic kidney disease. Lipids. 2002;37:1059–1065. doi: 10.1007/s11745-002-1001-4. [DOI] [PubMed] [Google Scholar]
- 62.Yamamoto S, Hagiwara S, Hidaka S, Shingu C, Goto K, Kashima K, et al. The anti-oxidant EPC-K1 attenuates renal ischemia-reperfusion injury in a rat model. Am J Nephrol. 2011;33:485–490. doi: 10.1159/000327820. [DOI] [PubMed] [Google Scholar]
- 63.Moghimian M, Abtahi-Eivary S-H, Jajarmy N, Shahri MK, Adabi J, Shokoohi M. Comparing the effect of flaxseed and fish oils on acute ischemia-reperfusion injury in the rat kidney. Crescent J Med Biol Sci. 2019;6:6–12. [Google Scholar]
- 64.Poorhassan M, Navae F, Mahakizadeh S, Bazrafkan M, Nikmehr B, Abolhassani F, et al. Flaxseed can reduce hypoxia-induced damages in rat testes. Int J Fertil Steril. 2018;12:235–241. doi: 10.22074/ijfs.2018.5298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565–4592. doi: 10.1210/jc.2013-2350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Nowak DA, Snyder DC, Brown AJ, Demark-Wahnefried W. The effect of flaxseed supplementation on hormonal levels associated with polycystic ovarian syndrome: a case study. Curr Top Nutraceutical Res. 2007;5:177–181. [PMC free article] [PubMed] [Google Scholar]
- 67.Farzana F, Sulaiman A, Ruckmani A, Vijayalakshmi K, Karunya Lakshmi G, Shri R. Effects of flax seeds supplementation in polycystic ovarian syndrome. Int J Pharm Sci Rev Res. 2015;31:113–119. [Google Scholar]
- 68.Nesbitt PD, Thompson LU. Lignans in homemade and commercial products containing flaxseed. Nutr Cancer. 1997;29:222–227. doi: 10.1080/01635589709514628. [DOI] [PubMed] [Google Scholar]
- 69.Uauy R, Solomons N. Diet, nutrition, and the life-course approach to cancer prevention. J Nutr. 2005;135:2934–2945. doi: 10.1093/jn/135.12.2934S. [DOI] [PubMed] [Google Scholar]
- 70.Martin RM, McCarthy A, Smith GD, Davies DP, Ben-Shlomo Y. Infant nutrition and blood pressure in early adulthood: the Barry Caerphilly Growth study. Am J Clin Nutr. 2003;77:1489–1497. doi: 10.1093/ajcn/77.6.1489. [DOI] [PubMed] [Google Scholar]
- 71.Prasad K. Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits. J Cardiovasc Pharmacol Ther. 2009;14:38–48. doi: 10.1177/1074248408330541. [DOI] [PubMed] [Google Scholar]
- 72.Prasad K, Mantha S, Muir A, Westcott N. Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem. 2000;206:141–150. doi: 10.1023/a:1007018030524. [DOI] [PubMed] [Google Scholar]
- 73.Soltanian N, Janghorbani M. A randomized trial of the effects of flaxseed to manage constipation, weight, glycemia, and lipids in constipated patients with type 2 diabetes. Nutr Metab. 2018;15:36–44. doi: 10.1186/s12986-018-0273-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Hu P, Mei Q-Y, Ma L, Cui W-G, Zhou W-H, Zhou D-S, et al. Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: engagement of anti-oxidant mechanism. Eur J Pharmacol. 2015;767:183–192. doi: 10.1016/j.ejphar.2015.10.024. [DOI] [PubMed] [Google Scholar]
- 75.Barre D, Mizier-Barre K, Stelmach E, Hobson J, Griscti O, Rudiuk A, et al. Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis—an invitation to further investigation into polypharmacy reduction. J Nutr Metab. 2012;2012:585170. doi: 10.1155/2012/585170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Gök M, Ulusu NN, Tarhan N, Tufan C, Ozansoy G, Arı N, et al. Flaxseed protects against diabetes-induced glucotoxicity by modulating pentose phosphate pathway and glutathione-dependent enzyme activities in rats. J Diet Suppl. 2016;13:339–351. doi: 10.3109/19390211.2015.1036188. [DOI] [PubMed] [Google Scholar]
- 77.Hadjighassem M, Kamalidehghan B, Shekarriz N, Baseerat A, Molavi N, Mehrpour M, et al. Oral consumption of α-linolenic acid increases serum BDNF levels in healthy adult humans. Nutr J. 2015;14 doi: 10.1186/s12937-015-0012-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Saad CT, Précoma DB, Merlini AB, Ioshii SO, Champosk AF. Evaluation of flaxseed effects on non-alcoholic fatty liver disease (NAFLD) in rabbits submitted to a hypercholesterolemic diet. Funct Foods Health Dis. 2014;4:442–450. [Google Scholar]
- 79.Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62:1081–1089. doi: 10.1161/HYPERTENSIONAHA.113.02094. [DOI] [PubMed] [Google Scholar]
- 80.Edel AL, Rodriguez-Leyva D, Maddaford TG, Caligiuri SP, Austria JA, Weighell W, et al. Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease. J Nutr. 2015;145:749–757. doi: 10.3945/jn.114.204594. [DOI] [PubMed] [Google Scholar]
- 81.Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, et al. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr. 2008;27:65–74. doi: 10.1080/07315724.2008.10719676. [DOI] [PubMed] [Google Scholar]
- 82.Hernández-Salazar M, Guevara-González RG, Cruz-Hernández A, Guevara-Olvera L, Bello-Pérez LA, Castaño-Tostado E, et al. Flaxseed (Linum usitatissimum and its total non-digestible fraction influence the expression of genes involved in azoxymethane-induced colon cancer in rats. Plant Foods Hum Nutr. 2013;68:259–267. doi: 10.1007/s11130-013-0372-y. [DOI] [PubMed] [Google Scholar]
- 83.Millman J, Okamoto S, Kimura A, Uema T, Higa M, Yonamine M, et al. Metabolically and immunologically beneficial impact of extra virgin olive and flaxseed oils on composition of gut microbiota in mice. Eur J Nutr. 2020;59:2411–2425. doi: 10.1007/s00394-019-02088-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Rizwan S, Naqshbandi A, Farooqui Z, Khan AA, Khan F. Protective effect of dietary flaxseed oil on arsenic-induced nephrotoxicity and oxidative damage in rat kidney. Food Chem Toxicol. 2014;68:99–107. doi: 10.1016/j.fct.2014.03.011. [DOI] [PubMed] [Google Scholar]
- 85.Sankaran D, Bankovic-Calic N, Cahill L, Peng CY-C, Ogborn MR, Aukema HM. Late dietary intervention limits benefits of soy protein or flax oil in experimental polycystic kidney disease. Nephron Exp Nephrol. 2007;106:122–128. doi: 10.1159/000104836. [DOI] [PubMed] [Google Scholar]
- 86.Jelodar G, Masoomi S, Rahmanifar F. Hydroalcoholic extract of flaxseed improves polycystic ovary syndrome in a rat model. Iran J Basic Med Sci. 2018;21:645–650. doi: 10.22038/IJBMS.2018.25778.6349. [DOI] [PMC free article] [PubMed] [Google Scholar]